Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study

INTRODUCTION: The goal of this study was to identify serum markers that are modulated by treatment with golimumab with or without methotrexate (MTX) and are associated with clinical response. METHODS: Sera were collected at weeks 0 and 4 from a total of 336 patients (training dataset, n = 100; test...

Descripción completa

Detalles Bibliográficos
Autores principales: Visvanathan, Sudha, Rahman, Mahboob U, Keystone, Edward, Genovese, Mark, Klareskog, Lars, Hsia, Elizabeth, Mack, Michael, Buchanan, Jacqui, Elashoff, Michael, Wagner, Carrie
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046519/
https://www.ncbi.nlm.nih.gov/pubmed/21083889
http://dx.doi.org/10.1186/ar3188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046519/
https://www.ncbi.nlm.nih.gov/pubmed/21083889
http://dx.doi.org/10.1186/ar3188

Ejemplares similares